A used fuel reprocessing plant in the southern Urals region of Russia is the most likely source of a release of the isotope ruthenium-106 detected across Europe in late 2017, a study has concluded. No incident has, however, been reported at the Mayak facility or any other Russian nuclear facility and Rosatom has always maintained this.
Regulation & Safety 30 July 2019
.jpg?ext=.jpg)
The US Department of Energy's National Nuclear Security Administration has awarded cooperative agreements for the production of molybdenum-99 to three US companies. The announcement came as one of the companies - Shine Medical Technologies - submitted an application to the Nuclear Regulatory Commission to produce medical isotopes at its new production facility in Janesville, Wisconsin.
Regulation & Safety 23 July 2019